Sirolimus 1 mg Tablet

Sirolimus 1 mg Tablet is unique because it does not inhibit cytokine gene transcription like other common immunosuppressants (such as Tacrolimus). Instead, it blocks the signal transduction that leads to T-cell activation, providing a different pathway of protection for transplant patients.

Key Clinical Benefits

• Organ Survival: Dramatically reduces the incidence of acute rejection in renal transplant recipients.

• Lung Function Support: The only FDA-approved treatment to stabilize lung function and improve quality of life for patients with LAM.

• Non-Nephrotoxic: Unlike Calcineurin Inhibitors (CNIs), Sirolimus is less likely to cause permanent kidney damage over long-term use.

• Vascular Health: Helps prevent the overgrowth of cells that can re-block arteries after a stent procedure.

Administration & Safety Protocols

1. Consistent Dosing: Take Sirolimus at the same time every day.

2. Food Consistency: You must take Sirolimus consistently either with or without food. Do not switch back and forth, as food affects how the drug is absorbed.

3. Whole Tablet: Swallow the tablet whole. Do not crush, chew, or break it, as this can interfere with the controlled release of the medicine.

4. Grapefruit Warning: Strictly avoid grapefruit and grapefruit juice, as they can dangerously increase the levels of Sirolimus in your blood.

5. Sun Protection: Sirolimus increases your risk of skin cancer. Use high-SPF sunscreen and wear protective clothing when outdoors.